Search Results - "Tang, Zhenfeng"

Identification and experimental validation of a tumor-infiltrating lymphocytes-related long noncoding RNA signature for prognosis of clear cell renal cell carcinoma by Deng, Yulin, Guo, Kai, Tang, Zhenfeng, Feng, Yuanfa, Cai, Shanghua, Ye, Jianheng, Xi, Yuanxue, Li, Jinchuang, Liu, Ren, Cai, Chao, Tan, Zeheng, Zhang, Yixun, Han, Zhaodong, Zeng, Guohua, Zhong, Weide

“…Clear cell renal cell carcinoma (ccRCC) is a common aggressive malignant tumor of the urinary system. Given the heterogeneity of the tumor microenvironment,…”
Get full text

FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation by Liu, Ren, Zou, Zhihao, Chen, Lingwu, Feng, Yuanfa, Ye, Jianheng, Deng, Yulin, Zhu, Xuejin, Zhang, Yixun, Lin, Jundong, Cai, Shanghua, Tang, Zhenfeng, Liang, Yingke, Lu, Jianming, Zhuo, Yangjia, Han, Zhaodong, Ling, Xiaohui, Liang, Yuxiang, Wang, Zongren, Zhong, Weide

“…Renal cell carcinoma (RCC) is one of the three major malignant tumors of the urinary system and originates from proximal tubular epithelial cells. Clear cell…”
Get full text

FCGR3A: A new biomarker with potential prognostic value for prostate cancer by Zha, Zeyu, Hong, Yuan, Tang, ZhenFeng, Du, Qiuling, Wang, Yan, Yang, Shengbang, Wu, Yongding, Tan, Huijing, Jiang, Funneng, Zhong, Weide

“…To screen target gene cluster by bioinformatics analysis and verify them by experiment and clinicopathological correlation analysis. We try to find a new…”
Get full text

Prognostic implication of heterogeneity and trajectory progression induced by enzalutamide in prostate cancer by Feng, Yuanfa, Deng, Yulin, Tang, Zhenfeng, Cai, Shanghua, Li, Jinchuang, Liu, Ren, Wan, Jiaming, He, Huichan, Zeng, Guohua, Ye, Jianheng, Han, Zhaodong, Zhong, Weide

“…Enzalutamide, as a second-generation endocrine therapy drug for prostate cancer (PCa), is prominent representative among the synthetic androgen receptor…”
Get full text

Identification and Validation of a PPP1R12A-Related Five-Gene Signature Associated With Metabolism to Predict the Prognosis of Patients With Prostate Cancer by Zou, Zhihao, Liu, Ren, Liang, Yingke, Zhou, Rui, Dai, Qishan, Han, Zhaodong, Jiang, Minyao, Zhuo, Yangjia, Zhang, Yixun, Feng, Yuanfa, Zhu, Xuejin, Cai, Shanghua, Lin, Jundong, Tang, Zhenfeng, Zhong, Weide, Liang, Yuxiang

“…Prostate cancer (PCa) is the most common malignant male neoplasm in the American male population. Our prior studies have demonstrated that protein phosphatase…”
Get full text

Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer by Han, Zhaodong, Mo, Rujun, Cai, Shanghua, Feng, Yuanfa, Tang, Zhenfeng, Ye, Jianheng, Liu, Ren, Cai, Zhiduan, Zhu, Xuejin, Deng, Yulin, Zou, Zhihao, Wu, Yongding, Cai, Zhouda, Liang, Yuxiang, Zhong, Weide

“…Given the tumor heterogeneity, most of the current prognostic indicators cannot accurately evaluate the prognosis of patients with prostate cancer, and thus,…”
Get full text

Genome-Scale CRISPR-Cas9 Transcriptional Activation Screening in Metformin Resistance Related Gene of Prostate Cancer by Chen, Jiahong, Huang, Yaqiang, Tang, Zhenfeng, Li, Maozhang, Ling, Xiaohui, Liao, Jinxian, Zhou, Xiaobo, Fang, Shumin, Zhao, Haibo, Zhong, Weide, Yuan, Xia

“…Metformin is a classic type II diabetes drug which possesses anti-tumor properties for various cancers. However, different cancers do not respond to metformin…”
Get full text

N1-methyladenosine RNA methylation patterns are associated with an increased risk to biochemical recurrence in prostate cancer and serve as a potential novel biomarker for patient stratification by Deng, Yulin, Tan, Zeheng, Cai, Shanghua, Feng, Yuanfa, Tang, Zhenfeng, Li, Jinchuang, He, Huichan, Wu, Zhenjie, Liu, Ren, Huang, Huiting, Ye, Jianheng, Han, Zhaodong, Zhong, Weide

“…[Display omitted] •The m1A regulator mediated RNA methylation pattern is associated with the lipid metabolism of prostate cancer.•The m1A subgroup with poor…”
Get full text

Ferrocene‐Based Polymeric Nanoparticles Carrying Doxorubicin for Oncotherapeutic Combination of Chemotherapy and Ferroptosis by Lin, Jundong, Yang, Huikang, Zhang, Yixun, Zou, Fen, He, Huichan, Xie, Wenjie, Zou, Zhihao, Liu, Ren, Xu, Qianfeng, Zhang, Jie, Zhong, Guowei, Li, Yuejiao, Tang, ZhenFeng, Deng, Yulin, Cai, Shanghua, Wang, Linyao, Huang, Yugang, Zhuo, Yangjia, Jiang, Xinqing, Zhong, Weide

“…Mono‐chemotherapy has significant side effects and unsatisfactory efficacy, limiting its clinical application. Therefore, a combination of multiple treatments…”
Get full text

ACOX2 Serves as a Favorable Indicator Related to Lipid Metabolism and Oxidative Stress for Biochemical Recurrence in Prostate Cancer by Tan, Zeheng, Deng, Yulin, Cai, Zhiduan, He, Huichan, Tang, Zhenfeng, Feng, Yuanfa, Ye, Jianheng, Liu, Ren, Cai, Shanghua, Huang, Huiting, Han, Zhaodong, Zhong, Weide, Guo, Kai

“…Given the heterogeneity of tumors, there is an urgent need for accurate prognostic parameters in prostate cancer (PCa) patients. Lipid metabolism (LM)…”
Get full text

Integrated analysis reveals prognostic value and progression-related role of AMIGO2 in prostate cancer by Han, Zhaodong, Feng, Yuanfa, Deng, Yulin, Tang, Zhenfeng, Cai, Shanghua, Zhuo, Yangjia, Liang, Yingke, Ye, Jianheng, Cai, Zhouda, Yang, Shuai, Liang, Yuxiang, Hon, Chi Tin, Chen, Jiahong, Zhong, Weide

“…BackgroundEven though emerging studies supplied evidence that Adhesion Molecule with Ig Like Domain family 2 (AMIGO2) plays a critical role in numerous…”
Get full text

The prognostic roles of CYP19A1 expression in bladder cancer patients of different genders by Cai, Shanghua, Feng, Yuanfa, Ye, Jianheng, Deng, Yulin, Cai, Zhiduan, Zhu, Xuejin, Liu, Ren, Zhang, Yixun, Zou, Zhihao, Tang, Zhenfeng, Han, Zhaodong, Hon, Chi Tin, Zhong, Weide, He, Huichan

“…The incidence of bladder cancer (BCa) in male is approximately three to four times higher than in female, but the oncological outcomes in female patients with…”
Get full text